Technology News and Research

RSS

Devil genome sequenced: Hope for endangered Tasmanian Devils

Tasmanian Devil Salem died at age seven but made a difference to her endangered species. Only 50 micrograms of her tissue was taken and processed by Australian genetic scientist Elizabeth Murchison, using new US technology, to produce the first devil genome sequence. As a result, the fight against devil facial tumor disease now has a draft DNA reference map. This was presented at a genetic conference in Hobart yesterday.

16 Sep 2010

Premier ranks 72 on 2010 InformationWeek 500 list

The Premier healthcare alliance and 26 of its more than 2,400 member hospitals have been named to the 2010 InformationWeek 500, a list of the top technology innovators in the nation. Premier was ranked 72 on the 2010 list, which was revealed last night at the InformationWeek 500 Conference in Dana Point, Calif.

16 Sep 2010

Velico Medical sells royalty rights to OrbiMed Advisors

Velico Medical, Inc. announced that it has sold to OrbiMed Advisors, LLC certain royalty rights Velico Medical has under an exclusive license agreement with a large biosurgical products company. Velico Medical retains all rights to use its technologies in its own business, the development of products for transfusion medicine.

16 Sep 2010

Cornerstone OnDemand to showcase Observation Checklist for evaluating performance

The ability to manage performance in industries such as healthcare, manufacturing and education can be a difficult task, especially when it comes to roles where employee performance is best monitored in real time and in relation to a very specific set of skills or competencies. With this in mind, Cornerstone OnDemand is adding an innovative new feature set to its comprehensive learning and talent management software solution, Observation Checklist.

16 Sep 2010

Lofty altitudes increase prevalence of suicides

The Intermountain West is renowned for the beauty of its towering mountains and high deserts, but according to new research from an investigator with the University of Utah Brain Institute the region's lofty altitudes significantly influence a deadly problem: the high prevalence of suicides in this part of the country.

16 Sep 2010

Endoscopic laser spine procedures replace traditional open back surgery

The Bonati Spine Institute, the leading center for the patented Bonati Spine Procedures for minimally invasive laser spine surgery, supports recent studies by highly respected organizations such as the Journal of the America Board of Family Medicine and Consumer Reports reporting an unnecessary growth in tests and treatments targeting back pain.

16 Sep 2010

NMS Labs launches method for K2 drug metabolites detection in urine

Of growing concern to public health officials and law enforcement is that routine drug testing cannot detect the use of the popular and highly intoxicating new drugs K2 and Spice. NMS Labs now has a full menu of tests that can detect the use of the designer chemicals present in these products, sold as incense or legal highs. A few weeks ago, NMS Labs launched a blood test to detect a range of these laboratory-designed synthetic drugs.

16 Sep 2010

Blue Cross, Blue Shield employees shed 2.80% of their total weight since Memorial Day

Three months and more than 37,000 pounds later, The Biggest Loser Summer Challenge has a winner: Blue Cross and Blue Shield of Minnesota and its employees, who lost more than 3,780 pounds or 2.80 percent of their total weight in pounds per employee since Memorial Day.

16 Sep 2010

Optical coherence tomography to penetrate intravascular ultrasound market: MRG

According to Millennium Research Group (MRG), the optical coherence tomography market will grow at an annual rate of almost 60% through 2015, spurred by physician adoption of this new technology that was launched in the US in May 2010.

16 Sep 2010

BioResonator signs new orders for glaucoma diagnostic product distribution

BioResonator signs new orders with several new distributors. As of one month, the company has the official CE approval required to sell their products throughout the European Union.

16 Sep 2010

Accunurse focuses on clinical informatics in long-term care sector

AccuNurse announces its leadership role with 'meaningful use' requirements by taking its product roadmap a significant step further toward helping long-term care providers prepare for an increasingly competitive market that will reward clinical outcomes.

16 Sep 2010

GORE C3 Delivery System enables repositioning of stent graft during procedure for AAA

W. L. Gore & Associates (Gore) today announced the first clinical uses of the GORE C3 Delivery System to deploy the GORE EXCLUDER AAA Endoprosthesis as a minimally invasive treatment for patients suffering from an abdominal aortic aneurysm (AAA).

16 Sep 2010

Professor named recipient of 2010 Phoenix Award Glass Person of the Year

Dr. Delbert Day, Curators' Professor emeritus of materials science and engineering at Missouri University of Science and Technology, has been named the 2010 Phoenix Award Glass Person of the Year, the glass industry's top honor. The Phoenix Award is given annually to a living person who has made outstanding contributions to the industry.

16 Sep 2010

Tetraphase Pharmaceuticals presents preclinical data of TP-434 antibacterial drug

Tetraphase Pharmaceuticals, Inc., today presented encouraging preclinical data for its lead drug candidate, TP-434, which showed the potent antibacterial activity of TP-434 against a very broad spectrum of susceptible and multidrug-resistant pathogens.

16 Sep 2010

Angioslide commercializes Proteus device for ECA in the U.S.

Angioslide, Inc. of Minneapolis, MN and Angioslide, Ltd. Herzliya, Israel, announced today that the company has commercialized the Proteus device for Embolic Capture Angioplasty in the United States. The device combines an angioplasty balloon and embolic capture feature into one device, thus providing physicians with a simple and cost-effective method of capturing of embolic particles during angioplasty procedures.

16 Sep 2010

BCBC Consortium aims to develop cell-based therapy for insulin delivery

Oregon Health & Science University's Markus Grompe, M.D., will lead a multi-center team of scientists selected to participate in the prestigious Beta Cell Biology Consortium (BCBC). Funded by the National Institute of Diabetes and Digestive and Kidney Diseases, the consortium's long-term goal is to develop a cell-based therapy for insulin delivery in type 1 diabetes patients.

16 Sep 2010

UCLA selected to help establish guidelines for health, safety of firefighters in the field

The David Geffen School of Medicine at UCLA and the UCLA Henry Samueli School of Engineering and Applied Science have been selected by the U.S. Department of Homeland Security's Science and Technology Directorate to help establish guidelines for the health and safety of firefighters in the field.

16 Sep 2010

U.N. Secretary-General taps former Chilean president to head U.N. Agency for Women

Michelle Bachelet, famous for breaking gender barriers by becoming the first woman elected president of Chile, will head the new global United Nations agency created to advance women's rights, Secretary General Ban Ki-moon announced Tuesday.

16 Sep 2010

New computerized catheter makes surgical treatment of atrial fibrillation faster, cheaper and more effective

Atrial fibrillation is a heart disorder that affects more than two million Americans, and is considered a key contributor to blood clots and stroke. Now researchers from North Carolina State University are developing a new computerized catheter that could make the surgical treatment of atrial fibrillation faster, cheaper and more effective - while significantly decreasing radiation exposure related to the treatment.

16 Sep 2010

K.U.Leuven enters license agreement with Pfizer to commercialize anti-HIV drugs

K.U.Leuven announced today that on July 29th, 2010 they entered into a license agreement with Pfizer. The license agreement grants Pfizer exclusive and sublicenseable worldwide rights to further develop and commercialise K.U.Leuven's compounds with a new mechanism of action for the potential treatment of individuals infected with HIV, the virus that causes AIDS.

16 Sep 2010